These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 10346865

  • 1. Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties.
    Ladd DL, Hollister R, Peng X, Wei D, Wu G, Delecki D, Snow RA, Toner JL, Kellar K, Eck J, Desai VC, Raymond G, Kinter LB, Desser TS, Rubin DL.
    Bioconjug Chem; 1999; 10(3):361-70. PubMed ID: 10346865
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
    Wen X, Jackson EF, Price RE, Kim EE, Wu Q, Wallace S, Charnsangavej C, Gelovani JG, Li C.
    Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P.
    Acc Chem Res; 2009 Jul 21; 42(7):851-62. PubMed ID: 19222207
    [Abstract] [Full Text] [Related]

  • 5. Comparison of a tartaric acid derived polymeric MRI contrast agent to a small molecule model chelate.
    Lucas RL, Benjamin M, Reineke TM.
    Bioconjug Chem; 2008 Jan 21; 19(1):24-7. PubMed ID: 18092744
    [Abstract] [Full Text] [Related]

  • 6. Tris(pyrone) chelates of Gd(III) as high solubility MRI-CA.
    Puerta DT, Botta M, Jocher CJ, Werner EJ, Avedano S, Raymond KN, Cohen SM.
    J Am Chem Soc; 2006 Feb 22; 128(7):2222-3. PubMed ID: 16478170
    [Abstract] [Full Text] [Related]

  • 7. Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review.
    Port M, Idée JM, Medina C, Robic C, Sabatou M, Corot C.
    Biometals; 2008 Aug 22; 21(4):469-90. PubMed ID: 18344005
    [Abstract] [Full Text] [Related]

  • 8. Tuning the magnetic resonance imaging properties of positive contrast agent nanoparticles by surface modification with RAFT polymers.
    Rowe MD, Chang CC, Thamm DH, Kraft SL, Harmon JF, Vogt AP, Sumerlin BS, Boyes SG.
    Langmuir; 2009 Aug 18; 25(16):9487-99. PubMed ID: 19422256
    [Abstract] [Full Text] [Related]

  • 9. Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity.
    Xu J, Churchill DG, Botta M, Raymond KN.
    Inorg Chem; 2004 Sep 06; 43(18):5492-4. PubMed ID: 15332797
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficient relaxivity enhancement in dendritic gadolinium complexes: effective motional coupling in medium molecular weight conjugates.
    Fulton DA, O'Halloran M, Parker D, Senanayake K, Botta M, Aime S.
    Chem Commun (Camb); 2005 Jan 28; (4):474-6. PubMed ID: 15654374
    [Abstract] [Full Text] [Related]

  • 12. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents.
    Laus S, Ruloff R, Tóth E, Merbach AE.
    Chemistry; 2003 Aug 04; 9(15):3555-66. PubMed ID: 12898682
    [Abstract] [Full Text] [Related]

  • 13. Dendrimeric gadolinium chelate with fast water exchange and high relaxivity at high magnetic field strength.
    Pierre VC, Botta M, Raymond KN.
    J Am Chem Soc; 2005 Jan 19; 127(2):504-5. PubMed ID: 15643857
    [Abstract] [Full Text] [Related]

  • 14. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P, Runge VM, Bücker A, Schürholz H, Reith W, Robert P, Jackson C, Lanz T, Schneider G.
    Invest Radiol; 2009 Apr 19; 44(4):200-6. PubMed ID: 19300099
    [Abstract] [Full Text] [Related]

  • 15. Contrast agents for magnetic resonance imaging synthesized with ring-opening metathesis polymerization.
    Allen MJ, Raines RT, Kiessling LL.
    J Am Chem Soc; 2006 May 24; 128(20):6534-5. PubMed ID: 16704234
    [Abstract] [Full Text] [Related]

  • 16. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.
    Caravan P.
    Chem Soc Rev; 2006 Jun 24; 35(6):512-23. PubMed ID: 16729145
    [Abstract] [Full Text] [Related]

  • 17. Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations.
    Fu Y, Raatschen HJ, Nitecki DE, Wendland MF, Novikov V, Fournier LS, Cyran C, Rogut V, Shames DM, Brasch RC.
    Biomacromolecules; 2007 May 24; 8(5):1519-29. PubMed ID: 17402781
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cyano-bridged coordination polymer nanoparticles with high nuclear relaxivity: toward new contrast agents for MRI.
    Guari Y, Larionova J, Corti M, Lascialfari A, Marinone M, Poletti G, Molvinger K, Guérin C.
    Dalton Trans; 2008 Jul 28; (28):3658-60. PubMed ID: 18615211
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.